The present narrative review aims to provide an overview of the immunomodulatory and anti-inflammatory roles of BCP and comprehensively summarizes the recent insights into the CB2R-mediated pharmacological properties and therapeutic potential of BCP as a novel natural approach for the management of several psychiatric conditions, with a focus on depression and anxiety. This evidence concerns the gene OPN1SW and major depressive disorder.